14-day Premium Trial Subscription Try For FreeTry Free
Date Action Amount Person Type
Apr 15, 2024 Sell 7 500 Raab Michael Common Stock
Apr 01, 2024 Sell 1 518 Raab Michael Common Stock
Mar 25, 2024 Buy 205 000 Kelliher Mike Stock Option (Right to Buy)
Mar 25, 2024 Buy 160 000 Kelliher Mike Common Stock
Mar 25, 2024 Buy 0 Kelliher Mike
Mar 20, 2024 Sell 86 000 Grammer Elizabeth A Common Stock
Mar 15, 2024 Sell 1 000 Blanks Robert Common Stock
Feb 26, 2024 Sell 5 183 Rosenbaum David P. Common Stock
Feb 20, 2024 Sell 5 017 Rosenbaum David P. Common Stock
Feb 20, 2024 Sell 2 294 Rosenbaum David P. Common Stock
Feb 20, 2024 Sell 5 341 Renz Justin A Common Stock
Feb 20, 2024 Sell 22 917 Raab Michael Common Stock
Feb 20, 2024 Sell 5 017 Blanks Robert Common Stock
Feb 20, 2024 Sell 4 432 Grammer Elizabeth A Common Stock
Feb 20, 2024 Sell 6 928 Rodriguez Susan Common Stock
Feb 20, 2024 Sell 2 352 Felsch Robert Ora Common Stock
Feb 20, 2024 Sell 4 803 Williams Laura A Common Stock
Feb 08, 2024 Sell 15 344 Rosenbaum David P. Common Stock
Jan 16, 2024 Buy 118 750 Williams Laura A Common Stock
Jan 16, 2024 Buy 152 127 Williams Laura A Stock Option (Right to Buy)
Jan 16, 2024 Buy 112 750 Rosenbaum David P. Common Stock
Jan 16, 2024 Buy 70 120 Rosenbaum David P. Common Stock
Jan 16, 2024 Buy 145 000 Rosenbaum David P. Stock Option (Right to Buy)
Jan 16, 2024 Buy 99 000 Rosenbaum David P. Stock Option (Right to Buy)
Jan 16, 2024 Buy 112 750 Rodriguez Susan Common Stock
Jan 16, 2024 Buy 145 000 Rodriguez Susan Stock Option (Right to Buy)
Jan 16, 2024 Buy 127 750 Renz Justin A Common Stock
Jan 16, 2024 Buy 164 000 Renz Justin A Stock Option (Right to Buy)
Jan 16, 2024 Buy 475 000 Raab Michael Common Stock
Jan 16, 2024 Buy 605 904 Raab Michael Stock Option (Right to Buy)
Jan 16, 2024 Buy 127 750 Grammer Elizabeth A Common Stock
Jan 16, 2024 Buy 164 000 Grammer Elizabeth A Stock Option (Right to Buy)
Jan 16, 2024 Buy 70 120 Felsch Robert Ora Common Stock
Jan 16, 2024 Buy 99 000 Felsch Robert Ora Stock Option (Right to Buy)
Jan 16, 2024 Buy 112 750 Blanks Robert Common Stock
Jan 16, 2024 Buy 145 000 Blanks Robert Stock Option (Right to Buy)
Jan 08, 2024 Sell 30 000 Rosenbaum David P. Common Stock
Dec 26, 2023 Buy 75 000 Renz Justin A Common Stock
Dec 26, 2023 Sell 225 000 Renz Justin A Common Stock
Dec 26, 2023 Sell 75 000 Renz Justin A Stock Option (Right to Buy)
Dec 18, 2023 Sell 5 675 Rosenbaum David P. Common Stock
Dec 14, 2023 Sell 7 000 Rosenbaum David P. Common Stock
Dec 11, 2023 Sell 50 000 Grammer Elizabeth A Common Stock
Dec 08, 2023 Sell 20 000 Rosenbaum David P. Common Stock
Dec 05, 2023 Sell 10 272 Rosenbaum David P. Common Stock
Nov 30, 2023 Sell 3 000 Rosenbaum David P. Common Stock
Nov 20, 2023 Sell 2 581 Williams Laura A Common Stock
Nov 20, 2023 Sell 2 835 Rosenbaum David P. Common Stock
Nov 20, 2023 Sell 932 Rosenbaum David P. Common Stock
Nov 20, 2023 Sell 4 714 Rodriguez Susan Common Stock
Nov 20, 2023 Sell 2 873 Renz Justin A Common Stock
Nov 20, 2023 Sell 11 368 Raab Michael Common Stock
Nov 20, 2023 Sell 2 384 Grammer Elizabeth A Common Stock
Nov 20, 2023 Sell 1 044 Felsch Robert Ora Common Stock
Nov 20, 2023 Sell 2 835 Blanks Robert Common Stock
Nov 15, 2023 Sell 25 000 Williams Laura A Common Stock
Oct 10, 2023 Sell 1 644 Rosenbaum David P. Common Stock
Sep 08, 2023 Sell 2 897 Rosenbaum David P. Common Stock
Aug 21, 2023 Sell 4 733 Rodriguez Susan Common Stock
Aug 21, 2023 Sell 2 591 Williams Laura A Common Stock
Aug 21, 2023 Sell 2 846 Rosenbaum David P. Common Stock
Aug 21, 2023 Sell 937 Rosenbaum David P. Common Stock
Aug 21, 2023 Sell 2 884 Renz Justin A Common Stock
Aug 21, 2023 Sell 11 419 Raab Michael Common Stock
Aug 21, 2023 Sell 2 392 Grammer Elizabeth A Common Stock
Aug 21, 2023 Sell 1 048 Felsch Robert Ora Common Stock
Aug 21, 2023 Sell 2 846 Blanks Robert Common Stock
Jun 27, 2023 Sell 25 000 Williams Laura A Common Stock
Jun 23, 2023 Buy 33 333 Blanks Robert Common Stock
Jun 23, 2023 Sell 33 333 Blanks Robert Common Stock
Jun 23, 2023 Sell 33 333 Blanks Robert Stock Option (Right to Buy)
Jun 15, 2023 Buy 49 237 Block Geoffrey A. Stock Option (Right to Buy)
Jun 15, 2023 Buy 12 755 Lundberg Jan M Common Stock
Jun 15, 2023 Buy 49 237 Lundberg Jan M Stock Option (Right to Buy)
Jun 15, 2023 Buy 49 237 Bhanji Muna Stock Option (Right to Buy)
Jun 15, 2023 Buy 12 755 Cadoret-manier Onaiza Common Stock
Jun 15, 2023 Buy 49 237 Cadoret-manier Onaiza Stock Option (Right to Buy)
Jun 15, 2023 Buy 18 494 Rodgers Richard J Common Stock
Jun 15, 2023 Buy 49 237 Rodgers Richard J Stock Option (Right to Buy)
Jun 15, 2023 Buy 16 581 Bertrand William C Jr Common Stock
Jun 15, 2023 Buy 49 237 Bertrand William C Jr Stock Option (Right to Buy)
Jun 15, 2023 Buy 25 510 Mott David M Common Stock
Jun 15, 2023 Buy 49 237 Mott David M Stock Option (Right to Buy)
Jun 15, 2023 Buy 49 237 Bazemore Robert B Stock Option (Right to Buy)
May 23, 2023 Sell 1 046 Felsch Robert Ora Common Stock
May 23, 2023 Sell 11 357 Raab Michael Common Stock
May 23, 2023 Sell 2 384 Grammer Elizabeth A Common Stock
May 23, 2023 Sell 2 835 Blanks Robert Common Stock
May 23, 2023 Sell 2 873 Renz Justin A Common Stock
May 23, 2023 Sell 4 711 Rodriguez Susan Common Stock
May 23, 2023 Sell 2 835 Rosenbaum David P. Common Stock
May 23, 2023 Sell 934 Rosenbaum David P. Common Stock
May 23, 2023 Sell 2 583 Williams Laura A Common Stock
Mar 29, 2023 Sell 3 000 Rosenbaum David P. Common Stock
Feb 21, 2023 Sell 5 586 Rodriguez Susan Common Stock
Feb 21, 2023 Sell 3 187 Williams Laura A Common Stock
Feb 21, 2023 Sell 3 394 Blanks Robert Common Stock
Feb 21, 2023 Sell 2 914 Grammer Elizabeth A Common Stock
Feb 21, 2023 Sell 13 449 Raab Michael Common Stock
Feb 21, 2023 Sell 3 214 Felsch Robert Ora Common Stock
INSIDER POWER
65.439
Last 100 transactions
Buy: 4 000 095 | Sell: 852 364 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 65.439.

In total, the insiders bought 4 000 095 and sold 852 364 ARDX shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Ardelyx

Ardelyx Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel syndrome with constipation, as well as in Phase III clinical trial to control serum phosphorus in adult pat... ARDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT